[Abstract] Different vaccine and adjuvant combinations are known to rapidly induce antigen presenting cell (APC) maturation and pro-inflammatory cytokine and production, which in turn play an important role in the priming of antigen-specific T cells. Measuring cytokine production systemically in the serum fails to detect localized responses in the lymph nodes draining a subcutaneous immunization site. On the other hand, stimulating APC with vaccine formulations in vitro lacks the complexity of the lymph node microenvironment and the presence of other in vivo factors. Here we analyse cytokine production directly in vaccine draining lymph nodes (dLN) extracted early after in vivo vaccination. To do this we perform cytokine multiplex analysis of supernatants from whole dLN cell suspensions following a brief ex vivo incubation.
systemically in the serum fails to detect localized responses in the lymph nodes draining a subcutaneous immunization site. On the other hand, stimulating APC with vaccine formulations in vitro lacks the complexity of the lymph node microenvironment and the presence of other in vivo factors. Here we analyse cytokine production directly in vaccine draining lymph nodes (dLN) extracted early after in vivo vaccination. To do this we perform cytokine multiplex analysis of supernatants from whole dLN cell suspensions following a brief ex vivo incubation. 2. Peptides were injected alone or in combination with 50 μg of one of the following adjuvants: CpG-ODN (CpG), HMW Poly (I: C), imiquimod, or Quil A.
Materials and Reagents
3. Either 12 or 24 h later, mice were euthanised by CO2 asphyxiation followed by cervical dislocation, and dLN (both inguinal LN) were excised.
4. LNs were rapidly transferred to a 24 well plate containing 250 μl of pre-warmed cIMDM + 5% FBS over a small square of 45 μm nylon gauze. A second piece of gauze was placed on top of the LN tissue, which was then dissociated by gently crushing with the rubber end of a 1 ml syringe plunger, while holding the mesh squares in place with forceps.
5. The cell suspension was then immediately pipetted into a 96 well u-bottom plate for incubation at 37 degrees for 1, 6 or 12 h.
6. The plate was centrifuged at 300 x g for 1 min before removing 65 μl of supernatant and freezing it at -20 degrees for later analysis. 2. On the day of analysis, samples were thawed at room temperature.
3. The protocol outlined in the Luminex manual was followed exactly.
4. Standards were reconstituted with a mixture composed of 50% assay diluent and 50% of cIMDM.
5. 50 μl of thawed sample was added to the luminex plate along with 50 μl of assay diluent during the analyte capture phase.
6. The samples were run on the Luminex ® 200™ system with xPONENT ® software according to the manufacturer's instructions.
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